	Burden and Trends of Nasopharyngeal Cancer Among Younger People in the Western Pacific Region, 1990 to 2021: Findings from the 2021 Global Burden of Disease Study. J Otolaryngol Head Neck Surg Zhou L, Ma G, Jia W, Zhang Y, Wu L, Ye Y, Liu D, Li X. PMID: 41572805 [PubMed - indexed for MEDLINE]
	Improved Overall Survival Due to Reduced Waiting Time in Nasopharyngeal Cancer Patients Treated with Chemoradiotherapy in Yogyakarta, Indonesia. Asian Pac J Cancer Prev Diessen JNAV, Ekaputra E, Tan B, Stoker S, Herdini C, Dhamiyati W, Dwidanarti R, Meidania L, Kurniawan T, Yanuarta S, Indrasari SR, Fles R. PMID: 41569188 [PubMed - indexed for MEDLINE]
	Toripalimab plus concurrent chemoradiotherapy for recurrent nasopharyngeal carcinoma: A single-arm, phase 2 clinical trial. Cancer Xiao Z, Liang Z, Huang H, Qin Y, Huang S, Wei J, Guan Y, Du Y, Su F, Li K, Liu Y, Wei J, Zeng F, Li Y, Wei C, Mo Y, Yu B, Qu S. PMID: 41548086 [PubMed - indexed for MEDLINE]
	Five-year comparison of magnetic resonance imaging and endoscopy for nasopharyngeal carcinoma detection among high-risk populations undergoing screening. Cancer Zhou HN, Li T, Peng YN, Li H, Wu ZC, Fan YY, King AD, Hildesheim A, Ling W, Liu Z, Cao SM. PMID: 41548058 [PubMed - indexed for MEDLINE]
	Predicting high lymph node positivity risk factors in nasopharyngeal carcinoma patients: A multi-model approach. Medicine (Baltimore) Liao H, He B, Yan F. PMID: 41517768 [PubMed - indexed for MEDLINE]
	Evaluation of Anti-BNLF2b Antibody and Epstein-Barr Virus Biomarkers for the Diagnosis of Nasopharyngeal Carcinoma: A Retrospective Study. Technol Cancer Res Treat Deng H, Liu Q, Shen H, Xiao P. PMID: 41505354 [PubMed - indexed for MEDLINE]
	Risk Factors of Malnutrition in Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy and Construction of a Predictive Model. J Nutr Sci Vitaminol (Tokyo) Zhan C, Gong Z, Ji N, Ju X. PMID: 41485969 [PubMed - indexed for MEDLINE]
	Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study. Medicina (Kaunas) Sali S, Abakay CD, Sali M, Güdücü H, Çak, Ocak B, , Co, Orhan SO, Ula, Deligönül A, Evrensel T, Çubukçu E. PMID: 41470209 [PubMed - indexed for MEDLINE]
	Functional genetic variants in immune-checkpoint molecules and susceptibility to Nasopharyngeal carcinoma in a Tunisian case-control study. Mol Biol Rep Gharbi W, Siala W, Abida O, Lahiani B, Feki S, Ben Amor I, Daoud J, Masmoudi H, Hachicha H. PMID: 41460376 [PubMed - indexed for MEDLINE]
	In vitro and in silico studies of anticancer activities of pectic acid and pectin oligosaccharide in Epstein-Barr virus-positive nasopharyngeal carcinoma. J Comput Aided Mol Des Mohan D, Khor BK, Murugaiyah V, Teh AH, Yap BK. PMID: 41460354 [PubMed - indexed for MEDLINE]
	Dosimetric Determinants of Locoregional Failure in Nasopharyngeal Carcinoma Treated with Definitive Intensity-modulated Radiotherapy (IMRT) with or without Concomitant Chemotherapy. Asian Pac J Cancer Prev Kalantari Khandani M, Javadinia SA, Nouri M. PMID: 41459851 [PubMed - indexed for MEDLINE]
	Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities. Br J Biomed Sci Chan SM, Paterson IC, Yap LF. PMID: 41459134 [PubMed - indexed for MEDLINE]
	Machine learning-based integration of radiomics and dosiomics for early prediction of radiation-induced temporal lobe injury in nasopharyngeal carcinoma: A multicenter study. J Appl Clin Med Phys Sun X, Zhu H, Qiao J, Liang Y, Zhu Z, Dong S, Wang J. PMID: 41456601 [PubMed - indexed for MEDLINE]
	Cochlear device explantation in patients with nasopharyngeal cancer irradiation. Cochlear Implants Int Chang WT, Ng IHY, Chen X, Lee WTW, Chu TC, Lau ATL, Wong BYH, Cheng H, Lui KCM, Tong MCF. PMID: 41453754 [PubMed - indexed for MEDLINE]
	Epigenomic landscape of nasopharyngeal carcinoma. Med Oncol Silmi Almohammadin SS, S M N Mydin RB, Bahar R, Sivasamy D, Musa MY. PMID: 41452386 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Epstein-Barr Virus Immunofluorescence and Enzyme-Immunoassay Platforms for Detecting IgA Antibodies in Nasopharyngeal Carcinoma in the Singaporean Cohort. J Med Virol Ng SH, Huang W, Seng EH, Ng Q, Yang Q, Thean SM, Ng WC, Loh KS, Tay JK, Lim CM, Wan WY. PMID: 41439796 [PubMed - indexed for MEDLINE]
	NPC-SurvAI: A fully automated deep learning framework for prognostic prediction and risk stratification in patients with nasopharyngeal carcinoma. Radiother Oncol You J, Ou H, Zhang Y, Wu X, Zhang L, Jin Z, Chen Q, Shen H, Liu X, Sun J, Zhao H, Luo C, Zhang S, Zhang B. PMID: 41429722 [PubMed - indexed for MEDLINE]
	Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy. Biochim Biophys Acta Rev Cancer Lu F, Bai X, Lv Z, Zhang W. PMID: 41429718 [PubMed - indexed for MEDLINE]
	Research progress on the regulation of ferroptosis in NPC (Review). Oncol Rep Bai S, Guo Y, Qiang J, Dai Q, Yang Y. PMID: 41416424 [PubMed - indexed for MEDLINE]
	Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis. Cancer Immunol Immunother Peng Y, Chu X, Zha D, Meng L, Yao J, Liu T, Liu Q, Xu X, Wang S, Chen M, You R, Liu Y. PMID: 41410705 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8950

Page 1 of 448



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy